A randomized trial of 2 prescription strategies for opioid treatment of chronic nonmalignant pain
- PMID: 21111684
- DOI: 10.1016/j.jpain.2010.09.003
A randomized trial of 2 prescription strategies for opioid treatment of chronic nonmalignant pain
Abstract
The use of opioid medications for treating chronic noncancer pain is growing; however, there is a lack of good evidence regarding their long-term effectiveness, association with substance abuse, and proper prescribing guidelines. The current study directly compares for the first time in a randomized trial the effectiveness of a conservative, hold the line (Stable Dose) prescribing strategy for opioid medications with a more liberal dose escalation (Escalating Dose) approach. This 2-arm, parallel, randomized pragmatic clinical trial followed 135 patients referred to a specialty pain clinic at a Veterans Affairs Hospital for 12 months (94% male and 74% with musculoskeletal pain). Primary outcomes included monthly or quarterly evaluations of pain severity, pain relief from medications, pain-related functional disability, and opioid misuse behaviors. All subjects received identical pain treatment except for the application of treatment group specific strategies for opioid prescriptions. No group differences were found for primary outcomes of usual pain or functional disability although the Escalating Dose group did show a small but significantly larger increase in self-rated pain relief from medications. About 27% of patients were discharged over the course of the study due to opioid misuse/noncompliance, but there were no group differences in rate of opioid misuse.
Perspective: The results of this study demonstrate that even in carefully selected patients there is a significant risk of problematic opioid misuse. Although in general there were no statistically significant differences in the primary outcomes between groups, the escalating dose strategy did lead to small improvements in self-reported acute relief from medications without an increase in opioid misuse, compared to the stable dose strategy.
Published by Elsevier Inc.
Similar articles
-
Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23. Pain Pract. 2008. PMID: 18503626
-
Analgesic efficacy and tolerability of intravenous morphine versus combined intravenous morphine and oxycodone in a 2-center, randomized, double-blind, pilot trial of patients with moderate to severe pain after total hip replacement.Clin Ther. 2012 Aug;34(8):1751-60. doi: 10.1016/j.clinthera.2012.06.023. Epub 2012 Jul 12. Clin Ther. 2012. PMID: 22795613 Clinical Trial.
-
Oral versus intravenous opioid dosing for the initial treatment of acute musculoskeletal pain in the emergency department.Acad Emerg Med. 2008 Dec;15(12):1234-40. doi: 10.1111/j.1553-2712.2008.00266.x. Epub 2008 Oct 17. Acad Emerg Med. 2008. PMID: 18945240 Clinical Trial.
-
Combination hydrocodone and ibuprofen versus combination codeine and acetaminophen for the treatment of chronic pain.Clin Ther. 2000 Jul;22(7):879-92. doi: 10.1016/S0149-2918(00)80060-0. Clin Ther. 2000. PMID: 10945514 Clinical Trial.
-
Patient selection and outcomes using a low-dose intrathecal opioid trialing method for chronic nonmalignant pain.Pain Physician. 2011 Jul-Aug;14(4):343-51. Pain Physician. 2011. PMID: 21785477 Review.
Cited by
-
Examining buprenorphine diversion through a harm reduction lens: an agent-based modeling study.Harm Reduct J. 2023 Oct 17;20(1):150. doi: 10.1186/s12954-023-00888-6. Harm Reduct J. 2023. PMID: 37848945 Free PMC article.
-
CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022.MMWR Recomm Rep. 2022 Nov 4;71(3):1-95. doi: 10.15585/mmwr.rr7103a1. MMWR Recomm Rep. 2022. PMID: 36327391 Free PMC article.
-
Digital Analgesic Comprising a Second-Generation Digital Health System: Increasing Effectiveness by Optimizing the Dosing and Minimizing Side Effects.J Pain Res. 2022 Apr 13;15:1051-1060. doi: 10.2147/JPR.S356319. eCollection 2022. J Pain Res. 2022. PMID: 35444460 Free PMC article. Review.
-
A systematic review of strategies to improve appropriate use of opioids and to reduce opioid use disorder and deaths from prescription opioids.Can J Pain. 2018 Jul 31;2(1):218-235. doi: 10.1080/24740527.2018.1479842. eCollection 2018. Can J Pain. 2018. PMID: 35005381 Free PMC article. Review.
-
Management of chronic musculoskeletal pain in veterans: a systematic review.Acta Biomed. 2021 Mar 31;92(S2):e2021011. doi: 10.23750/abm.v92iS2.11352. Acta Biomed. 2021. PMID: 33855991 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical